Project background:

Drug procurement and agency is an important link in the field of pharmaceutical circulation, involving drug manufacturers, circulation enterprises, medical institutions, patients and other interests. In recent years, with the increasing supervision of drug price, quality and circulation, the drug procurement and agency market is facing great changes and challenges. How to adapt to policy changes, grasp market opportunities, and enhance competitiveness is the core issue of drug procurement and agency companies.

Customer pain points:

A large drug procurement and agency company (hereinafter referred to as a customer) has multiple branches and subsidiaries across the country, operating multiple categories and varieties of drugs, and has established long-term cooperative relations with many well-known pharmaceutical companies. Customers want to know their market position in each region of the country, competitive advantages and disadvantages, as well as future development trends and opportunities. At the same time, customers also want to understand the strategy, scale, channels, services, etc. of competitors, as well as the best practices and innovation models in the industry.

Project purpose:

20239In January, Shangpu Consulting Company (hereinafter referred to as Shangpu) was entrusted by the client to carry out a comprehensive and in-depth drug procurement and agency market research project, which aims to help the client:

-Assess its core indicators such as market share, growth rate and profitability in all regions of the country;

-Investigate their own strengths and weaknesses in different drug types, sales channels, service models, etc;

-Identify the opportunities and challenges they face in the market, as well as future development directions and strategies;

-Understand the basic situation of competitors, strategic layout, operation mode, market performance, etc;

-Learn from successful cases and innovative practices in the industry to enhance their competitiveness and value.

Research object:

Champ collects a large amount of primary and secondary data in a number of ways, including:

-On-site visits and in-depth interviews with customers' branches and subsidiaries in various regions of the country.20home unit, covering the main business scope of the customer;

-The customer's partners (including pharmaceutical manufacturers, medical institutions, pharmacies, etc.) conducted telephone interviews or online questionnaires, a total of interviews100Home units, understand the customer's service quality, credibility, satisfaction, etc;

-Public information collection and secret customer surveys of the client's main competitors were conducted, and a total10The data of the home unit, the research of its strategic direction, market size, channel layout, service characteristics, etc;

-Data collection and expert consultation were conducted on authoritative organizations in the industry (such as China Pharmaceutical Business Association, National Health Insurance Administration, etc.), and a total20Reports and literature to capture industry policy dynamics, market trends, best practices, etc.

Project Content:

According to the customer's needs and research data, Shangpu has formulated the following project contents:

-The overall current situation of the drug procurement and agency market: the scale, structure, growth trend, regional distribution, competition pattern, etc. of the drug procurement and agency market are introduced;

-Drug procurement and agency market segmentation research: according to drug types (such as Chinese patent medicine, western medicine, biological products, etc.), sales channels (such as hospitals, pharmacies, online sales, etc.), service models (such as one-vote system, two-vote system,CSOetc.) and other dimensions, investigating the characteristics, size, growth rate, market share, etc. of each market segment;

-Customer self-evaluation research: Assessed the customer's market performance in various regions of the country, including core indicators such as market share, growth rate, profitability, and the advantages and disadvantages of different drug types, sales channels, service models, etc., and identified The opportunities and challenges faced by customers in the market, as well as the future development direction and strategy;

-Competitor research: investigated the basic situation, strategic layout, operation mode, market performance, etc. of the customer's main competitors, compared the differences and advantages and disadvantages between customers and competitors, and put forward targeted suggestions;

-Industry best practices and innovation cases: learn from the successful cases and innovation practices in the industry, including well-known enterprises or emerging enterprises at home and abroad, show their outstanding performance and innovation mode in the drug procurement and agency market, and provide reference and inspiration for customers.

Project Value:

-Help customers to fully understand the current situation and future of the drug procurement and agency market, and provide data support and decision-making basis for customers to formulate reasonable development goals and strategies;

-Help customers to conduct in-depth research on their own strengths and weaknesses, and provide guidance, suggestions and improvement plans for customers to optimize their business structure and operation mode;

-Help customers gain insight into competitors' trends and strategies, and provide customers with powerful weapons and methods to deal with market competition;

-Help customers learn best practices and innovative cases in the industry, and provide inspiration and reference for customers to enhance their competitiveness and value.

With its professional team, rich experience, precise methods and efficient execution, Shangpu Consulting has provided customers with satisfactory project services and won high recognition and trust from customers. Shangpu Consulting looks forward to maintaining long-term cooperative relations with customers and jointly promoting the healthy development of the drug procurement and agency market.